Opinion of the President – Treatment of patients with chronic hepatitis C with non-interferon therapy
On 11 February 2025, the President of the Agency for Health Technology Assessment and Tariff System issued opinion No. 12/2025 on the appropriateness of introducing changes to the drug program B.71 Treatment of patients with chronic hepatitis C with non-interferon therapy (ICD-10: B18.2)
Publication in Public Information Bulletin (BIP) >>